Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 1998

BenevolentAI co-founder returns with plan to save drug developer

$
0
0
Can Ken Mulvany save BenevolentAI? About a decade ago, Mulvany helped found the company as part of the first generation of AI-focused biotech startups. It soared to a $2 billion valuation, pitching a “bioscience machine ...

Viewing all articles
Browse latest Browse all 1998

Trending Articles